Targeted Interdisciplinary Model for Evaluation and Treatment of Neuropsychiatric Symptoms (TIME) in home care services: a cluster randomized feasibility trial.
Anxiety
BPSD
Community-dwelling patients
Dementia
Depression
Home care services
Neuropsychiatric symptoms
Nonpharmacological interventions
Person-centered care
Psychosocial interventions
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
29 Mar 2022
29 Mar 2022
Historique:
received:
03
11
2021
accepted:
23
03
2022
entrez:
30
3
2022
pubmed:
31
3
2022
medline:
1
4
2022
Statut:
epublish
Résumé
Behavioral and psychological symptoms of dementia (BPSD) occur frequently in people with dementia and can contribute to an increased need for help and a reduced quality of life, but also predict early institutionalization. The Targeted Interdisciplinary Model for Evaluation and Treatment of Neuropsychiatric Symptoms (TIME) might be a useful personalized approach to BPSD in people with dementia. The main objective of this feasibility trial was to explore the trial design and methods along with the patients' and the home care staff's acceptance of the TIME intervention before developing a definitive trial. Additionally, we wanted to explore whether TIME could be appropriate for staff in home care services in their approach towards people with dementia with anxiety and depression. This was a 18-month feasibility trial using a parallel cluster randomized controlled design. Nine municipalities from the eastern part of Norway (clusters) - 40 people with dementia and 37 of their next of kin- were randomized to the TIME intervention or to treatment as usual. In addition, qualitative data as field notes were collected and summarized. The staff in home care services experienced TIME as an appropriate method; in particular, the systematic approach to the patient's BPSD was experienced as useful. However, the completion of the assessment phase was considered exhaustive and time-consuming, and some of the staff found it challenging to find time for the case conferences. We consider that TIME, with some adjustments, could be useful for staff in home care services in cases where they face challenges in providing care and support to people with dementia. This feasibility trial indicates that we can move forward with a future definitive randomized controlled trial (RCT) to test the effect of TIME in people with dementia receiving home care services. ClinicalTrial.gov identifier: SI0303150608.
Sections du résumé
BACKGROUND
BACKGROUND
Behavioral and psychological symptoms of dementia (BPSD) occur frequently in people with dementia and can contribute to an increased need for help and a reduced quality of life, but also predict early institutionalization. The Targeted Interdisciplinary Model for Evaluation and Treatment of Neuropsychiatric Symptoms (TIME) might be a useful personalized approach to BPSD in people with dementia. The main objective of this feasibility trial was to explore the trial design and methods along with the patients' and the home care staff's acceptance of the TIME intervention before developing a definitive trial. Additionally, we wanted to explore whether TIME could be appropriate for staff in home care services in their approach towards people with dementia with anxiety and depression.
METHODS
METHODS
This was a 18-month feasibility trial using a parallel cluster randomized controlled design. Nine municipalities from the eastern part of Norway (clusters) - 40 people with dementia and 37 of their next of kin- were randomized to the TIME intervention or to treatment as usual. In addition, qualitative data as field notes were collected and summarized.
RESULTS
RESULTS
The staff in home care services experienced TIME as an appropriate method; in particular, the systematic approach to the patient's BPSD was experienced as useful. However, the completion of the assessment phase was considered exhaustive and time-consuming, and some of the staff found it challenging to find time for the case conferences.
CONCLUSIONS
CONCLUSIONS
We consider that TIME, with some adjustments, could be useful for staff in home care services in cases where they face challenges in providing care and support to people with dementia. This feasibility trial indicates that we can move forward with a future definitive randomized controlled trial (RCT) to test the effect of TIME in people with dementia receiving home care services.
TRIAL REGISTRATION
BACKGROUND
ClinicalTrial.gov identifier: SI0303150608.
Identifiants
pubmed: 35351124
doi: 10.1186/s12913-022-07830-9
pii: 10.1186/s12913-022-07830-9
pmc: PMC8961099
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
415Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2022. The Author(s).
Références
WHO. Dementia 2020 [Available from: https://www.who.int/news-room/fact-sheets/detail/dementia .
Gjøra L, Strand BH, Bergh S, Borza T, Brækhus A, Engedal K, et al. Current and future prevalence estimates of mild cognitive impairment, dementia, and its subtypes in a population-based sample of people 70 years and older in Norway: the hunt study. 2021.
doi: 10.3233/JAD-201275
Ministry of Health and Care Services. Meld. St. 15 (2017–2018) Leve hele livet - en kvalitetsmelding for eldre 2018 [cited 2020 Sept]. Available from: https://www.regjeringen.no/contentassets/196f99e63aa14f849c4e4b9b9906a3f8/no/pdfs/stm201720180015000dddpdfs.pdf .
Ministry of Health and care services. Demensplan 2025. Oslo2020 [cited 2021 Jan]. Available from: https://www.regjeringen.no/contentassets/b3ab825ce67f4d73bd24010e1fc05260/demensplan-2025.pdf .
WHO. Gobal action plan on the public health response to dementia 2017–2025 Switzerland: World Health Organization; 2017 [cited 2020 12.09]. Available from: https://www.who.int/mental_health/neurology/dementia/action_plan_2017_2025/en/ .
Hoel K-A, Rokstad AMM, Feiring IH, Lichtwarck B, Selbaek G, Bergh S. Staff’s perspectives on the organization of homecare services to people with dementia-a qualitative study. Nurs Open. 2021;8(4):1797–804.
doi: 10.1002/nop2.822
Black W, Almeida OP. A systematic review of the association between the behavioral and psychological symptoms of dementia and burden of care. Int Psychogeriatr. 2004;16(3):295–315.
doi: 10.1017/S1041610204000468
Balestreri L, Grossberg A, Grossberg GT. Behavioral and psychological symptoms of dementia as a risk factor for nursing home placement. Int Psychogeriatr. 2000;12(S1):59–62.
doi: 10.1017/S1041610200006773
Finkel SI, Costa e Silva J, Cohen G, Miller S, Sartorius N. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr. 1997;8(S3):497–500.
doi: 10.1017/S1041610297003943
Cerejeira J, Lagarto L, Mukaetova-Ladinska EB. Behavioral and psychological symptoms of dementia. Front Neurol. 2012;3:73.
doi: 10.3389/fneur.2012.00073
Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatniek J, et al. Neuropsychiatric symptoms in Alzheimer’s disease. Alzheimers Dement. 2011;7(5):532–9.
doi: 10.1016/j.jalz.2011.05.2410
Allegri RF, Sarasola D, Serrano CM, Taragano FE, Arizaga RL, Butman J, et al. Neuropsychiatric symptoms as a predictor of caregiver burden in Alzheimer’s disease. Neuropsychiatr Dis Treat. 2006;2(1):105–10.
pubmed: 19412452
pmcid: 2671738
Kales HC, Gitlin LN, Lyketsos CG. Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel. J Am Geriatr Soc. 2014;62(4):762–9.
doi: 10.1111/jgs.12730
Savva GM, Zaccai J, Matthews FE, Davidson JE, McKeith I, Brayne C. Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population. Br J Psychiatry. 2009;194(3):212–9.
doi: 10.1192/bjp.bp.108.049619
Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the lancet commission. Lancet (British edition). 2020;396(10248):413–46.
Chenoweth L, Stein-Parbury J, Lapkin S, Wang A, Liu Z, Williams A. Effects of person-centered care at the organisational-level for people with dementia. A systematic review. PLoS One. 2019;14(2):e0212686-e.
doi: 10.1371/journal.pone.0212686
Kales HC, Gitlin LN, Lyketsos CG. Assessment and management of behavioral and psychological symptoms of dementia. BMJ. 2015;350(mar02 7):h369-h.
doi: 10.1136/bmj.h369
van der Linde RM, Dening T, Stephan BCM, Prina AM, Evans E, Brayne C. Longitudinal course of behavioural and psychological symptoms of dementia: systematic review. Br J Psychiatry. 2016;209(5):366–77.
doi: 10.1192/bjp.bp.114.148403
Hwang TJ, Masterman DL, Ortiz F, Fairbanks LA, Cummings JL. Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms. Alzheimer Dis Assoc Disord. 2004;18(1):17–21.
doi: 10.1097/00002093-200401000-00004
Borsje P, Lucassen PLBJ, Bor H, Wetzels RB, Pot AM, Koopmans RT. The course of neuropsychiatric symptoms in patients with dementia in primary care. Fam Pract. 2019;36(4):437–44.
doi: 10.1093/fampra/cmy117
Wergeland JN, Selbæk G, Høgset LD, Söderhamn U, Kirkevold Ø. Dementia, neuropsychiatric symptoms, and the use of psychotropic drugs among older people who receive domiciliary care: a cross-sectional study. Int Psychogeriatr. 2014;26(3):383–91.
doi: 10.1017/S1041610213002032
Lichtwarck B, Selbæk G, Kirkevold Ø, Rokstad AMM, Saltyte BJ, Lindstrøm JC, et al. Targeted interdisciplinary model for evaluation and treatment of neuropsychiatric symptoms : a cluster randomized controlled trial. Am J Geriatr Psychiatry. 2018;26(1):25–38.
doi: 10.1016/j.jagp.2017.05.015
Lichtwarck B, Tverå A-M, Røen I. Targeted Interdisciplinary Model for Evaluation and Treatment of neuropsychiatric symtoms. Manual. 2015;2:2–30.
Kitwood T. Dementia reconsidered: the person comes first. Buckingham: Open University Press; 1997.
Hawton KE SP, Kirk JE, Clark DM. Cognitive behaviour therapy for psychiatric problems: a practical guide. Oxford: Oxford University Press; 1989.
Lichtwarck B, Myhre J, Goyal AR, Rokstad AMM, Selbaek G, Kirkevold Ø, et al. Experiences of nursing home staff using the targeted interdisciplinary model for evaluation and treatment of neuropsychiatric symptoms (TIME) - a qualitative study. Aging Ment Health. 2019;23(8):966–75.
doi: 10.1080/13607863.2018.1464116
Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016;355:1–29.
Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566–72.
doi: 10.1192/bjp.140.6.566
Cummings LJ. The neuropsychiatric inventory: assessing psychopathology in dementia patients. Neurology. 1997;48(5 Suppl 6):10S-S16.
doi: 10.1212/WNL.48.5_Suppl_6.10S
Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell scale for depression in dementia. Biol Psychiatry. 1988;23(3):271–84.
doi: 10.1016/0006-3223(88)90038-8
Barca ML, Engedal K, Selbæk G. A reliability and validity study of the cornell scale among elderly inpatients, using various clinical criteria. Dement Geriatr Cogn Disord. 2010;29(5):438–47.
doi: 10.1159/000313533
Røen I, Selbæk G, Kirkevold Ø, Engedal K, Lerdal A, Bergh S. The reliability and validity of the Norwegian version of the quality of life in late-stage dementia scale. Dement Geriatr Cogn Disord. 2015;40(3–4):233–42.
doi: 10.1159/000437093
Weiner MF, Martin-Cook K, Svetlik DA, Saine K, Foster B, Fontaine CS. The quality of life in late-stage dementia (QUALID) scale. J Am Med Dir Assoc. 2000;1(3):114–6.
pubmed: 12818023
Greene JG, Smith R, Gardiner M, Timbury GC. Measuring behavioural disturbance of elderly demented patients in the community and its effects on relatives: a factor analytic study. Age Ageing. 1982;11(2):121–6.
doi: 10.1093/ageing/11.2.121
Galindo-Garre F, Volicer L, van der Steen JT. Factors related to rejection of care and behaviors directed towards others: a longitudinal study in nursing home residents with dementia. Dement Geriatr Cogn Dis Extra. 2015;5(1):123–34.
doi: 10.1159/000369158
Fazio S, Pace D, Flinner J, Kallmyer B. The Fundamentals of person-centered care for individuals with dementia. Gerontologist. 2018;58(suppl_1):S10–9.
doi: 10.1093/geront/gnx122
Brooker D. What is person-centered care in dementia? Rev Clin Gerontol. 2003;13(3):215–22.
doi: 10.1017/S095925980400108X
Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS-2 tool: designing trials that are fit for purpose. BMJ. 2015;350(may08 1):h2147-h.
doi: 10.1136/bmj.h2147
Rokstad AMM, Vatne S, Engedal K, Selbæk G. The role of leadership in the implementation of person-centred care using dementia care mapping: a study in three nursing homes. J Nurs Manag. 2015;23(1):15–26.
doi: 10.1111/jonm.12072
Chaplin S. Assessment, management and support of people with dementia. Prescriber. 2018;29(11):14–7.
doi: 10.1002/psb.1716
Clare L, Kudlicka A, Oyebode JR, Jones RW, Bayer A, Leroi I, et al. Individual goal-oriented cognitive rehabilitation to improve everyday functioning for people with early-stage dementia: a multicentre randomised controlled trial (the GREAT trial). Int J Geriatr Psychiatry. 2019;34(5):709–21.
doi: 10.1002/gps.5076